Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Chronic Cough Trials

View:

Post by nodaytrader on Jan 11, 2023 8:49pm

Chronic Cough Trials

In response to recent comments:

1. Christopher Moreau has stated that AGN's chronic cough study will mirror the Merck and Bellus studies so that direct comparisons can be made.
2. The study will include participants in the USA - presumably the new medical board advisor can help with that.
3. Both Merck and Bellus are quoted on NASDAQ. AGN is not.
If AGN were valued on the same basis as Bellus ($1.25 billion), its share price would be over $500.

226

Comment

Comment by C10H12N2 on Jan 12, 2023 9:09am

What Christopher Moreau (CEO) says and what actually happens tends not to usually align with what one would assume. Thus, I've clearly stated the "multinational" clinical trial(s) have had the vast majority of participants located outside of North America with none/zero participants in Canada. My guess is that will be the same strategy as before. OAN: I'm also guessing ...more

117

Comment

Algernon Pharmaceuticals Inc.